ENDRA LIFE SCIENCES INC. Revenue, Net (Deprecated 2018-01-31)
ENDRA LIFE SCIENCES INC. (NDRA) reported Revenue, Net (Deprecated 2018-01-31) of $6.17 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-05-15
- ENDRA LIFE SCIENCES INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $6.17K.
- ENDRA LIFE SCIENCES INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $6.85K, a 98.67% decline year-over-year.
- ENDRA LIFE SCIENCES INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $287.00K.
- ENDRA LIFE SCIENCES INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $57.77K.
- ENDRA LIFE SCIENCES INC. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $351.62K, a 31.80% decline from fiscal 2016.
- ENDRA LIFE SCIENCES INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $515.58K.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $6.17K 10-Q · filed 2018-05-15 | $13.02K derived: sum of 2 quarters · filed 2018-05-15 | $300.02K derived: sum of 3 quarters · filed 2018-05-15 | $357.80K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | $6.85K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $293.85K derived: sum of 2 quarters · filed 2018-03-20 | $351.62K derived: sum of 3 quarters · filed 2018-03-20 | $351.62K 10-K · filed 2018-03-20 |
| 2017-09-30 | $287.00K 10-Q · filed 2017-11-14 | $344.77K derived: sum of 2 quarters · filed 2017-11-14 | $344.77K 10-Q · filed 2017-11-14 | $860.35K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-06-30 | $57.77K 10-Q · filed 2017-08-07 | $57.77K 10-Q · filed 2017-08-07 | $573.35K derived: sum of 3 quarters · filed 2018-05-15 | $573.35K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-15 | $515.58K derived: sum of 2 quarters · filed 2018-05-15 | $515.58K derived: sum of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | $515.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $515.58K derived: sum of 2 quarters · filed 2018-03-20 | $515.58K 10-K · filed 2018-03-20 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |